Azelis Acquires Polish Specialty Chemicals Distributor Hortimex

Azelis has signed an agreement to acquire 100% of the shares of Hortimex, a specialty chemicals distributor active in the food ingredients and nutraceuticals segments serving the Polish market.

The acquisition, which is expected to close in the fourth quarter, upon fulfilment of customary transaction conditions, expands the Antwerp-based distribution group’s footprint in Poland, complementing Azelis’ lateral value chain in the Food & Nutrition segment. Azelis is active in this market thanks to its Regional Competence Center for Meat and Meat Alternatives, based in Poznań, Poland, while Hortimex is a well-established distributor of food ingredients with a particular focus on non-meat applications, such as human nutrition, functional preparations, confectionery, and bakery.

The acquisition represents an opportunity for the specialty chemicals and ingredients distributor to serve local customers better and accelerate growth in Poland, thanks to an extensive product range, experienced sales and technical teams, and long-standing business relationships with principals.

Established in 1988 by the Kowalewski family and based in Konin, Hortimex has grown to be a leader in health ingredients and specialty products to food production companies in Poland. The company is supported by a team of 35 employees, including experienced sales and technical specialists, serving over 800 customers.

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read